Five-year survival rates improved greatly because of immunotherapy and other advances, according to the American Cancer ...

But many existing models fall short of adhering to established best practices for economic evaluation, the review authors ...

Ozempic, Rybelsus and Wegovy top the list of the newest drugs selected for Medicare Part price negotiation, part of the ...

Mayo Clinic researchers find that stem cells with the highest Myc expression become dominant in driving lung remodeling .

Michael Poku, M.D., chief clinical officer of Equality Health, shared his prediction for 2025.

As 2025 approaches, the healthcare landscape is undergoing rapid transformation. Rising healthcare utilization, escalating ...

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

A prediction for 2025 from Laura Kohlhagen, M.D., MBA, chief medical officer, of Altera Digital Health.

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.

Cancer mortality rates have decreased by 34% overall, but incidence rates for women of all ages continue to rise, according ...

The 1.0 era of isolated telehealth is finally dead. We’re thrilled to welcome the new era of connected telehealth. In this ...